- Agrees to Sell its 4G IoT Technology for $200M to Qualcomm While Retaining License for Ongoing Use and Development
- Management to Hold a Conference Call Today, August 23, at 8:30 am ET
Paris, France--(Newsfile Corp. - August 23, 2024) - Sequans Communications S.A. (NYSE: SQNS) ("Sequans" or the "Company"), a leading developer and provider of 5G/4G semiconductors and IoT modules, today announced preliminary financial results for the second quarter ended June 30, 2024.
Second Quarter 2024 Summary Preliminary Results Table: | (in US$ millions, except share and per share data) | | | Q2 2024 (1) | | | Q1 2024 | | | Q2 2023 | |
| Revenue | | | $9.7 | | | $6.0 | | | $9.2 | |
| Gross profit | | | $8.1 | | | $3.9 | | | $7.5 | |
| Gross margin (%) | | | 84 % | | | 63.9 % | | | 82.3 % | |
| Operating loss | | | ($3.7 | ) | | ($8.5 | ) | | ($5.4 | ) |
| Net loss | | | ($0.9 | ) | | ($11.8 | ) | | ($9.1 | ) |
| Diluted loss per ADS | | | ($0.01 | ) | | ($0.19 | ) | | ($0.16 | ) |
| Non-IFRS diluted loss per ADS * | | | ($0.09 | ) | | ($0.14 | ) | | ($0.10 | ) |
| Weighted average number of diluted ADS (IFRS) | | | 61,912,657 | | | 61,613,761 | | | 57,119,468 | |
| Weighted average number of diluted ADS (Non-IFRS) | | | 61,912,657 | | | 61,613,761 | | | 57,119,468 | |
| (1) Final results are subject to finalization of the allocation of the Qualcomm transaction proceeds | |
| * See Use of Non-IFRS/non-GAAP Financial Measures disclosure on page 3. IFRS Net Loss includes significant non-cash interest expense, debt amendment and change in value of embedded derivative that are excluded from Non-IFRS measures | |
"Our second quarter revenue was $9.7M, representing a 5.4% increase year-over-year and a 60.5% sequential increase. License and services revenue accounted for 75% of it, largely driven by the Monarch 2 manufacturing license agreement that we announced on June 18, 2024, which we can now disclose was with Qualcomm. Note however, that our Q2 2024 results presented here are subject to change based on the final allocation of the purchase price of the new Qualcomm deal we have just announced," said Georges Karam, CEO of Sequans.
A joint
press release issued earlier today announced that Qualcomm Technologies, Inc. ("Qualcomm"), a subsidiary of Qualcomm Incorporated, will acquire Sequans' 4G IoT technologies. Sequans, in addition to retaining full ownership of 5G intellectual property, will retain the right to sell, support, maintain and enhance its existing 4G product portfolio and develop new generations of chips and modules using such technologies. This deal enables Sequans to advance its Monarch (LTE-M/NB-IoT), Calliope (LTE Cat-1/Cat-1bis), and Cassiopeia (LTE Cat-4/Cat-6) lines, along with 5G RedCap and eRedCap product developments. This transaction will not affect Sequans' existing contractual obligations or operations with customers, suppliers, and industry partners. It is expected to close by the end of October 2024, and is subject to customary closing conditions, including French regulatory approval.
Karam continued, "We are excited to enter into this transaction with Qualcomm. This transaction validates our LTE-M/NB-IoT and Cat 1bis technologies and strengthens our balance sheet. Retaining ownership of our 5G technology and a perpetual 4G license allows us to continue selling the Monarch and Calliope products families and expand towards 5G RedCap and eRedCap, enabling our continued growth and innovation."
Under the terms of the agreement with Qualcomm, Sequans will receive $185 million in cash, with $175 million payable at closing and up to an additional $10 million following the completion of a one-year warranty period. The remaining $15 million was paid under the pre-transaction manufacturing license agreement that was executed in June 2024 and will be credited toward the $200 million purchase price.
Q3 2024 Outlook As the allocation of the purchase price of the pending Qualcomm transaction will not be finalized until the 4
th quarter, we are not able to provide the expected impact of this deal on our licensing and services results for the second half of this year. Focusing on product revenue, we anticipate a modest increase in the third quarter compared to Q2 and a further stronger performance in the fourth quarter of 2024. Overall, due to the anticipated increase in products moving into mass production over the coming quarters, we expect higher product revenue for the full year of 2025 compared to 2024.
Second Quarter 2024 Financial Summary: Revenue: Revenue was $9.7 million, an increase of 60.5% compared to the first quarter of 2024 and an increase of 5.6% compared to the second quarter of 2023. Product revenue was $2.4 million, flat compared to the first quarter of 2024 and an increase of 144.5% compared to the second quarter of 2023. License and services revenue was $7.2 million, largely driven by the Monarch 2 manufacturing license agreement announced on June 18, 2024, and offsetting lowered licensing revenue from our Chinese strategic partner.
Gross margin: Gross margin was 84.0% compared to 63.9% in the first quarter of 2024 and 82.3% in the second quarter of 2023.
Operating loss: Operating loss was $3.7 million compared to $8.5 million in the first quarter of 2024 and $5.4 million in the second quarter of 2023.
Net loss: Net loss was $0.9 million, or ($0.01) per diluted ADS, compared to $11.8 million, or ($0.19) per diluted ADS, in the first quarter of 2024 and $9.1 million, or ($0.16) per diluted ADS, in the second quarter of 2023. Net loss in the second quarter of 2024 includes a gain of $13.6 million related to the impact of the debt extension, a gain of $39,000 on the change in fair value of the convertible debt derivative compared to a loss of $36,000 in the first quarter of 2024 and a gain of $0.3 million in the second quarter of 2023.
Non-IFRS loss and diluted loss per ADS: Excluding the non-cash stock-based compensation, the non-cash impact of the fair-value, the effective interest adjustments related to the convertible debt with embedded derivatives and other financings, non-IFRS net loss was $5.8 million, or ($0.09) per diluted ADS, compared to $8.8 million, or ($0.14) per diluted ADS in the first quarter of 2024, and $6.0 million, or ($0.10) per diluted ADS, in the second quarter of 2023. The non-IFRS net loss includes a foreign exchange gain of $90,000 in the second quarter of 2024, compared to a foreign exchange gain of $0.3 million in the first quarter of 2024 and a foreign exchange loss of $40,000 in the second quarter of 2023.
Cash: Cash and cash equivalents at June 30, 2024 totaled $13.1 million compared to $0.5 million at March 31, 2024. This amount includes $5 million from issuance of an unsecured promissory note in April 2024 and the $15 million upfront payment from the licensing agreement received in June 2024.
Conference Call Details Date: Friday, August 23, 2024
Time: 8:00 a.m. ET / 14:00 CET
Dial in: U.S. toll-free: 1-800-717-1738
International: +33 800 94 51 20
Access: When prompted, provide the event title or access code 1181953
A live and archived webcast of the call will be available from the Investor Relations section of the Sequans website at
www.sequans.com/investors/webcasts-and-presentations. An audio replay of the conference call will be available until August 30, 2024, by dialing toll-free 1-844-512-2921 in the U.S. or +1 412-317-6671 from outside the U.S., using the following access coder: 1181953
Forward-Looking Statements This press release contains certain statements that are, or may be deemed to be, forward-looking statements with respect to the financial condition, results of operations and business of Sequans, including our business following completion of the transaction. These forward-looking statements include, but are not limited to, statements regarding the satisfaction of conditions to the completion of the proposed transaction and the expected completion of the proposed transaction, the timing and benefits thereof, as well as other statements that are not historical fact. These forward-looking statements can be identified by the fact that they do not relate to historical or current facts. Forward-Looking statements also often use words such as "anticipate," "target," "continue," "estimate," "expect," "forecast," "intend," "may," "plan," "goal," "believe," "hope," "aims," "continue," "could," "project," "should," "will" or other words of similar meaning. These statements are based on assumptions and assessments made by Sequans in light of its experience and perception of historical trends, current conditions, future developments and other factors they believe appropriate. By their nature, forward-looking statements involve risk and uncertainty, because they relate to events and depend on circumstances that will occur in the future and the factors described in the context of such forward-looking statements in this announcement could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to be correct, and you are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this announcement.
Forward-Looking statements are not guarantees of future performance. Such forward-looking statements involve known and unknown risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Such risks and uncertainties include, but are not limited to, the potential failure to satisfy conditions to the completion of the proposed transaction due to the failure to obtain necessary regulatory or other approvals; the outcome of legal proceedings that may be instituted against Sequans and/or others relating to the transaction; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction; significant or unexpected costs, charges or expenses resulting from the proposed transaction; and negative effects of this announcement or the consummation of the proposed transaction on the market price of Sequans' ADS and ordinary shares. Many factors could cause actual results to differ materially from those projected or implied in any forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are changes in the global, political, economic, business and competitive environments, market and regulatory forces. If any one or more of these risks or uncertainties materializes or if any one or more of the assumptions prove incorrect, actual results may differ materially from those expected, estimated or projected. Such forward looking statements should therefore be construed in the light of such factors. A more complete description of these and other material risks can be found in Sequans' filings with the SEC, including its annual report on Form 20-F for the year ended December 31, 2023, subsequent filings on Form 6-K and other documents that may be filed from time to time with the SEC. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this announcement. Sequans undertakes no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by applicable law.
Use of Non-IFRS/non-GAAP Financial Measures To supplement our unaudited consolidated financial statements prepared in accordance with IFRS, we disclose certain non-IFRS, or non-GAAP, financial measures. These measures exclude the non-cash stock-based compensation and the non-cash impacts of convertible debt extensions, effective interest adjustments related to the convertible debt with embedded derivatives and other financings; deferred tax benefit or expense related to the convertible debt and other financings. We believe that these measures can be useful to facilitate comparisons among different companies. These non-GAAP measures have limitations in that the non-GAAP measures we use may not be directly comparable to those reported by other companies. We seek to compensate for this limitation by providing a reconciliation of the non-GAAP financial measures to the most directly comparable IFRS measures in the table attached to this press release.
About Sequans Communications Sequans Communications S.A. (NYSE: SQNS) is a leading semiconductor company specialized in wireless cellular technology for the Internet of Things (IoT). Our engineers design and develop innovative, secure, and scalable technologies that power the next generation of connected devices. We offer a wide range of solutions, including chips, modules, IP and services. Our Monarch (NB-IoT/LTE-M), Calliope (LTE Cat 1/Cat 1bis), and Taurus (5G NR) platforms are optimized for IoT, delivering breakthroughs in wireless connectivity, power efficiency, security, and performance.
Established in 2003, Sequans is headquartered in France and has a global presence with offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Finland, Taiwan, and China. Visit Sequans online at
www.sequans.com, and follow us on X and Linked-In.
Sequans investor relations: Kim Rogers (USA), +1 385.831.7337,
ir@sequans.com Sequans media relations: Linda Bouvet (France), +33 170721600,
media@sequans.com Condensed financial tables follow
SEQUANS COMMUNICATIONS S.A. PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | | | Three months ended | |
(in thousands of US$, except share and per share
amounts) | | | June 30,
2024 (1) | | | Mar 31,
2024 | | | June 30,
2023 | |
| |
| | | | | | | | | | |
| Revenue : | | | | | | | | | | |
| Product revenue | | $ | 2,435 | | $ | 2,468 | | $ | 996 | |
| License and services revenue | | | 7,240 | | | 3,559 | | | 8,162 | |
| Total revenue | | | 9,675 | | | 6,027 | | | 9,158 | |
| Cost of revenue | | | 1,547 | | | 2,173 | | | 1,625 | |
| Gross profit | | | 8,128 | | | 3,854 | | | 7,533 | |
| Operating expenses : | | | | | | | | | | |
| Research and development | | | 5,789 | | | 6,613 | | | 6,346 | |
| Sales and marketing | | | 3,131 | | | 2,872 | | | 2,982 | |
| General and administrative | | | 2,916 | | | 2,902 | | | 3,588 | |
| | | | | | | | | | |
| Total operating expenses | | | 11,836 | | | 12,387 | | | 12,916 | |
| Operating profit (loss) | | | (3,708 | ) | | (8,533 | ) | | (5,383 | ) |
| Financial income (expense): | | | | | | | | | | |
| Interest income (expense), net | | | (10,806 | ) | | (3,318 | ) | | (2,796 | ) |
| Change in fair value of convertible debt derivative | | | 39 | | | (36 | ) | | 325 | |
| Impact of debt amendment | | | 13,620 | | | - | | | - | |
| Foreign exchange gain (loss) | | | 90 | | | 264 | | | (40 | ) |
| Profit (Loss) before income taxes | | | (765 | ) | | (11,623 | ) | | (7,894 | ) |
| Income tax expense | | | 146 | | | 167 | | | 1,223 | |
| Profit (Loss) | | $ | (911 | ) | $ | (11,790 | ) | $ | (9,117 | ) |
| Attributable to : | | | | | | | | | | |
| Shareholders of the parent | | | (911 | ) | | (11,790 | ) | | (9,117 | ) |
| Minority interests | | | - | | | - | | | - | |
| Basic loss per ADS | | | ($0.01 | ) | | ($0.19 | ) | | ($0.16 | ) |
| Diluted loss per ADS | | | ($0.01 | ) | | ($0.19 | ) | | ($0.16 | ) |
| Weighted average number of ADS used for computing: | | | | | | | | | | |
| - Basic | | | 61,912,657 | | | 61,613,761 | | | 57,119,468 | |
| - Diluted | | | 61,912,657 | | | 61,613,761 | | | 57,119,468 | |
| (1) Final results are subject to finalization of the allocation of the Qualcomm deal transaction proceeds | |
SEQUANS COMMUNICATIONS S.A. PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | | | Six months ended June 30, | |
| (in thousands of US$, except share and per share amounts) | | | 2024 (1) | | | 2023 | |
| | | | | | | |
| Revenue : | | | | | | | |
| Product revenue | | $ | 4,903 | | $ | 3,336 | |
| License and services revenue | | | 10,799 | | | 17,721 | |
| Total revenue | | | 15,702 | | | 21,057 | |
| Cost of revenue | | | 3,720 | | | 4,181 | |
| Gross profit | | | 11,982 | | | 16,876 | |
| Operating expenses : | | | | | | | |
| Research and development | | | 12,402 | | | 13,834 | |
| Sales and marketing | | | 6,003 | | | 6,015 | |
| General and administrative | | | 5,818 | | | 6,406 | |
| | | | | | | |
| Total operating expenses | | | 24,223 | | | 26,255 | |
| Operating profit (loss) | | | (12,241 | ) | | (9,379 | ) |
| Financial income (expense): | | | | | | | |
| Interest income (expense), net | | | (14,124 | ) | | (5,311 | ) |
| Change in fair value of convertible debt derivative | | | 3 | | | 2,627 | |
| Impact of debt amendment | | | 13,620 | | | - | |
| Foreign exchange gain (loss) | | | 354 | | | (205 | ) |
| Profit (Loss) before income taxes | | | (12,388 | ) | | (12,268 | ) |
| Income tax expense | | | 313 | | | 1,889 | |
| Profit (Loss) | | $ | (12,701 | ) | $ | (14,157 | ) |
| Attributable to : | | | | | | | |
| Shareholders of the parent | | | (12,701 | ) | | (14,157 | ) |
| Minority interests | | | - | | | - | |
| Basic loss per ADS | | | ($0.21 | ) | | ($0.27 | ) |
| Diluted loss per ADS | | | ($0.21 | ) | | ($0.27 | ) |
| Weighted average number of ADS used for computing: | | | | | | | |
| - Basic | | | 61,764,688 | | | 52,774,984 | |
| - Diluted | | | 61,764,688 | | | 52,774,984 | |
| (1) Final results are subject to finalization of the allocation of the Qualcomm deal transaction proceeds | |
SEQUANS COMMUNICATIONS S.A. PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION | | | At June 30, | | | At Dec 31, | |
| (in thousands of US$) | | | 2024 (1) | | | 2023 | |
| ASSETS | | | | | | | |
| Non-current assets | | | | | | | |
| Property, plant and equipment | | $ | 5,570 | | $ | 6,815 | |
| Intangible assets | | | 75,732 | | | 64,300 | |
| Deposits and other receivables | | | 3,234 | | | 801 | |
| Other non-current financial assets | | | 349 | | | 360 | |
| Total non-current assets | | | 84,885 | | | 72,276 | |
| Current assets | | | | | | | |
| Inventories | | | 4,523 | | | 6,335 | |
| Trade receivables | | | 2,636 | | | 8,115 | |
| Contract assets | | | 219 | | | 497 | |
| Prepaid expenses | | | 1,500 | | | 1,422 | |
| Other receivables | | | 7,651 | | | 4,839 | |
| Research tax credit receivable | | | 7,727 | | | 9,983 | |
| Cash and cash equivalents | | | 13,108 | | | 5,705 | |
| Total current assets | | | 37,364 | | | 36,896 | |
| Total assets | | $ | 122,249 | | $ | 109,172 | |
| EQUITY AND LIABILITIES | | | | | | | |
| Equity | | | | | | | |
| Issued capital, euro 0.01 nominal value, 248,694,416 shares authorized, issued and outstanding at June 30, 2024 (246,262,004 shares at December 31, 2023) | | $ | 2,905 | | $ | 2,878 | |
| Share premium | | | 14,542 | | | 14,568 | |
| Other capital reserves | | | 73,378 | | | 70,261 | |
| Accumulated deficit | | | (106,063 | ) | | (93,362 | ) |
| Other components of equity | | | (685 | ) | | (416 | ) |
| Total equity | | | (15,923 | ) | | (6,071 | ) |
| Non-current liabilities | | | | | | | |
| Government grant advances, loans and other liabilities | | | 7,908 | | | 3,256 | |
| Lease liabilities | | | 1,120 | | | 1,645 | |
| Provisions | | | 1,932 | | | 2,222 | |
| Deferred tax liabilities | | | 263 | | | 264 | |
| Total non-current liabilities | | | 11,223 | | | 7,387 | |
| Current liabilities | | | | | | | |
| Trade payables | | | 14,935 | | | 16,281 | |
| Interest-bearing receivables financing | | | 6,204 | | | 9,544 | |
| Lease liabilities | | | 1,301 | | | 1,471 | |
| Convertible debt | | | 48,846 | | | 52,278 | |
| Convertible debt embedded derivative | | | - | | | 3 | |
| Unsecured related party loan | | | 25,897 | | | 8,922 | |
| Government grant advances and loans | | | 7,380 | | | 4,606 | |
| Contract liabilities | | | 10,954 | | | 5,852 | |
| Other current liabilities and provisions | | | 11,432 | | | 8,899 | |
| Total current liabilities | | | 126,949 | | | 107,856 | |
| Total equity and liabilities | | $ | 122,249 | | $ | 109,172 | |
| (1) Final results are subject to finalization of the allocation of the Qualcomm deal transaction proceeds |
PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW | | | Six months ended June 30, | |
| (in thousands of US$) | | | 2024 (1) | | | 2023 | |
| Operating activities | | | | | | | |
| Profit (Loss) before income taxes | | $ | (12,388 | ) | $ | (12,268 | ) |
| Non-cash adjustment to reconcile income before tax to net cash from (used in) operating activities | | | | | | | |
| Depreciation and impairment of property, plant and equipment | | | 1,670 | | | 1,953 | |
| Amortization and impairment of intangible assets | | | 2,748 | | | 4,669 | |
| Share-based payment expense | | | 2,964 | | | 3,559 | |
| Decrease in provisions | | | (219 | ) | | (1 | ) |
| Interest expense, net | | | 14,124 | | | 5,311 | |
| Change in the fair value of convertible debt embedded derivative | | | (3 | ) | | (2,627 | ) |
| Convertible debt amendment | | | (13,620 | ) | | - | |
| Foreign exchange loss (gain) | | | 216 | | | 281 | |
| Working capital adjustments | | | | | | | |
| Decrease (Increase) in trade receivables and other receivables | | | 5,209 | | | (5,163 | ) |
| Decrease (increase) in inventories | | | 1,812 | | | 983 | |
| Increase in research tax credit receivable | | | (987 | ) | | (1,211 | ) |
| Increase (Decrease) in trade payables and other liabilities | | | 792 | | | 1,040 | |
| Decrease in contract liabilities | | | 5,102 | | | (621 | ) |
| Decrease in government grant advances | | | 3,112 | | | (333 | ) |
| Income tax paid | | | (560 | ) | | (794 | ) |
| Net cash flow used in operating activities | | | 9,972 | | | (5,222 | ) |
| Investing activities | | | | | | | |
| Purchase of intangible assets and property, plant and equipment | | | (1,200 | ) | | (2,118 | ) |
| Capitalized development expenditures | | | (14,851 | ) | | (11,931 | ) |
| Sale (Purchase) of financial assets | | | 60 | | | 28 | |
| Decrease of short-term deposit | | | - | | | - | |
| Interest received | | | 27 | | | 99 | |
| Net cash flow used in investments activities | | | (15,964 | ) | | (13,922 | ) |
| Financing activities | | | | | | | |
| Proceeds (Repayment of) from interest-bearing receivables financing | | | 577 | | | (910 | ) |
| Proceeds from loans | | | 14,000 | | | - | |
| Proceeds from interest-bearing research project financing | | | 934 | | | 545 | |
| Payment of lease liabilities | | | (753 | ) | | (657 | ) |
| Repayment of government loans | | | (679 | ) | | (782 | ) |
| Repayment of interest-bearing research project financing | | | (266 | ) | | (693 | ) |
| Interest paid | | | (412 | ) | | (694 | ) |
| Net cash flows from financing activities | | | 13,401 | | | 16,364 | |
| Net increase (decrease) in cash and cash equivalents | | | 7,409 | | | (2,780 | ) |
| Net foreign exchange difference | | | (6 | ) | | 2 | |
| Cash and cash equivalents at January 1 | | | 5,705 | | | 5,671 | |
| Cash and cash equivalents at end of the period | | | 13,108 | | | 2,893 | |
| (1) Final results are subject to finalization of the allocation of the Qualcomm deal transaction proceeds | |
SEQUANS COMMUNICATIONS S.A. PRELIMINARY UNAUDITED RECONCILIATION OF NON-IFRS FINANCIAL RESULTS | (in thousands of US$, except share and per share amounts) | | | Three months ended | |
| | | June 30,
2024 (3) | | | March 31,
2024 | | | June 30,
2023 | |
| Net IFRS gain (loss) as reported | | $ | (911 | ) | $ | (11,790 | ) | $ | (9,117 | ) |
| Add back | | | | | | | | | | |
| Non-cash stock-based compensation expense according to IFRS 2 (1) | | | 1,847 | | | 1,117 | | | 1,778 | |
| Non-cash change in the fair value of convertible debt embedded derivative | | | (39 | ) | | 36 | | | (325 | ) |
| Non-cash interest on convertible debt and other financing (2) | | | 6,972 | | | 1,833 | | | 1,706 | |
| Non-cash impact of convertible debt amendment | | | (13,620 | ) | | - | | | - | |
| Non-IFRS gain (loss) adjusted | | $ | (5,751 | ) | $ | (8,804 | ) | $ | (5,958 | ) |
| IFRS basic gain (loss) per ADS as reported | | | ($0.01 | ) | | ($0.19 | ) | | ($0.16 | ) |
| Add back | | | | | | | | | | |
| Non-cash stock-based compensation expense according to IFRS 2 (1) | | $ | 0.03 | | $ | 0.02 | | $ | 0.04 | |
| Non-cash change in the fair value of convertible debt embedded derivative | | $ | 0.00 | | $ | 0.00 | | | ($0.01 | ) |
| Non-cash interest on convertible debt and other financing (2) | | $ | 0.11 | | $ | 0.02 | | $ | 0.03 | |
| Non-IFRS basic gain (loss) per ADS | | | ($0.09 | ) | | ($0.14 | ) | | ($0.10 | ) |
| IFRS diluted gain (loss) per ADS | | | ($0.01 | ) | | ($0.19 | ) | | ($0.16 | ) |
| Add back | | | | | | | | | | |
| Non-cash stock-based compensation expense according to IFRS 2 (1) | | $ | 0.03 | | $ | 0.02 | | $ | 0.04 | |
| Non-cash change in the fair value of convertible debt embedded derivative | | $ | 0.00 | | $ | 0.00 | | | ($0.01 | ) |
| Non-cash interest on convertible debt and other financing (2) | | $ | 0.10 | | $ | 0.02 | | $ | 0.03 | |
| Non-cash impact of convertible debt amendment | | | ($0.22 | ) | $ | 0.00 | | $ | 0.00 | |
| Non-IFRS diluted gain (loss) per ADS | | | ($0.09 | ) | | ($0.14 | ) | | ($0.10 | ) |
| | | | | | | | | | |
| (1) Included in the IFRS loss as follows: | | | | | | | | | | |
| Cost of product revenue | | $ | 27 | | $ | 17 | | $ | 27 | |
| Research and development | | | 509 | | | 318 | | | 488 | |
| Sales and marketing | | | 435 | | | 243 | | | 361 | |
| General and administrative | | | 876 | | | 539 | | | 902 | |
| (2) Related to the difference between contractual and effective interest rates | |
| (3) Final results are subject to finalization of the allocation of the Qualcomm deal transaction proceeds | |
SEQUANS COMMUNICATIONS S.A. PRELIMINARY UNAUDITED RECONCILIATION OF NON-IFRS FINANCIAL RESULTS | (in thousands of US$, except share and per share amounts) | | | Six months ended June 30, | |
| | | 2024 (3) | | | 2023 | |
| Net IFRS gain (loss) as reported | | $ | (12,701 | ) | $ | (14,157 | ) |
| Add back | | | | | | | |
| Non-cash stock-based compensation expense according to IFRS 2 (1) | | | 2,964 | | | 3,559 | |
| Non-cash change in the fair value of convertible debt embedded derivative | | | (3 | ) | | (2,627 | ) |
| Non-cash interest on convertible debt and other financing (2) | | | 8,805 | | | 3,114 | |
| Non-cash impact of deferred tax income (loss) | | | - | | | - | |
| Impact of debt reimbursement | | | - | | | - | |
| Non-cash impact of convertible debt amendment | | | (13,620 | ) | | - | |
| Non-IFRS gain (loss) adjusted | | $ | (14,555 | ) | $ | (10,111 | ) |
| IFRS basic gain (loss) per ADS as reported | | | ($0.21 | ) | | ($0.27 | ) |
| Add back | | | | | | | |
| Non-cash stock-based compensation expense according to IFRS 2 (1) | | $ | 0.05 | | $ | 0.07 | |
| Non-cash change in the fair value of convertible debt embedded derivative | | $ | 0.00 | | | ($0.05 | ) |
| Non-cash interest on convertible debt and other financing (2) | | $ | 0.14 | | $ | 0.06 | |
| Non-cash impact of deferred tax income (loss) | | $ | 0.00 | | $ | 0.00 | |
| Impact of debt reimbursement | | $ | 0.00 | | $ | 0.00 | |
| Non-cash impact of convertible debt amendment | | | ($0.22 | ) | $ | 0.00 | |
| Non-IFRS basic gain (loss) per ADS | | | ($0.24 | ) | | ($0.19 | ) |
| IFRS diluted gain (loss) per ADS | | | ($0.21 | ) | | ($0.27 | ) |
| Add back | | | | | | | |
| Non-cash stock-based compensation expense according to IFRS 2 (1) | | $ | 0.05 | | $ | 0.07 | |
| Non-cash change in the fair value of convertible debt embedded derivative | | $ | 0.00 | | | ($0.05 | ) |
| Non-cash interest on convertible debt and other financing (2) | | $ | 0.14 | | $ | 0.06 | |
| Non-cash impact of deferred tax income (loss) | | $ | 0.00 | | $ | 0.00 | |
| Impact of debt reimbursement | | $ | 0.00 | | $ | 0.00 | |
| Non-cash impact of convertible debt amendment | | | ($0.22 | ) | $ | 0.00 | |
| Non-IFRS diluted gain (loss) per ADS | | | ($0.24 | ) | | ($0.19 | ) |
| | | | | | | |
| (1) Included in the IFRS loss as follows: | | | | | | | |
| Cost of product revenue | | $ | 44 | | $ | 59 | |
| Research and development | | | 827 | | | 958 | |
| Sales and marketing | | | 678 | | | 708 | |
| General and administrative | | | 1,415 | | | 1,834 | |
| (2) Related to the difference between contractual and effective interest rates | | | | |
| (3) Final results are subject to finalization of the allocation of the Qualcomm deal transaction proceeds | |
The issuer is solely responsible for the content of this announcement.
